Shilov, S.V.,
Ustenova, G.O.,
Kiyekbayeva, L.N.,
Korotetskiy, I.S.,
Kudashkina, N.V.,
Zubenko, N.V.,
Parenova, R.A.,
Jumagaziyeva, A.B.,
Iskakbayeva, Z.A.,
Kenesheva, S.T. (2022) . In this study, for the
first time, we investigated the component composition and biological activity of various
Wu, JN,
Al-Zahrani, A,
Beylerli, O,
Sufianov, R,
Talybov, R,
Meshcheryakova, S,
Sufianova, G,
Gareev, I,
Sufianov, A (2022) predictors of OS in high-grade glioma patients.
Conclusions: Our data, for the
first time, demonstrated
Akhkiamova, Maria,
Polyakov, Aleksander,
Marakhonov, Andrey,
Voronin, Sergey,
Saifullina, Elena,
Vafina, Zulfiia,
Michalchuk, Kristina,
Braslavskaya, Svetlana,
Chukhrova, Alena,
Ryadninskaya, Nina,
Kutsev, Sergey,
Shchagina, Olga (2024) atrophy (5q SMA). Within the 253-sample risk group formed based on the results of the
first screening